Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2400 of 3173 entries
View as:

A Study to Evaluate the Efficacy of Somatropin in Adults With Growth Hormone Deficiency Caused by Trauma and/or Head Injury

Phase: N/A Priority: Normal
NCT ID: NCT00638053 Org: User:
Start: 11/30/02 End: 11/30/03 Due: 11/30/04

A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01393626 Org: User:
Start: 10/31/11 End: 03/31/15 Due: 03/31/16

Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections

Phase: N/A Priority: Normal
NCT ID: NCT01893346 Org: User:
Start: 07/31/13 End: 10/31/14 Due: 10/31/15

Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME II)

Phase: N/A Priority: Normal
NCT ID: NCT00679601 Org: User:
Start: 03/31/07 End: 05/31/07 Due: 05/31/08

Group Study To Investigate The Safety, Toleration And Pharmacokinetics Of Multiple Oral Doses Of PF-04531083 In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01012310 Org: User:
Start: 11/30/09 End: 04/30/10 Due: 04/30/11

Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00143390 Org: User:
Start: 04/30/05 End: 12/31/10 Due: 12/31/11

A Study To Investigate And Describe The Treatment Patterns And Effect Of Tofacitinib Indicators For Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT04721808 Org: User:
Start: 01/22/21 End: 11/24/21 Due: 11/24/22

Prevenar (PCV-7) Post-Licensure Safety Study In Russia

Phase: N/A Priority: Normal
NCT ID: NCT01207583 Org: User:
Start: 12/31/09 End: 08/31/11 Due: 08/31/12

A Pharmacokinetic (PK) Study Of PF-00299804 And Dextromethorphan In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00999817 Org: User:
Start: 11/30/09 End: 12/31/09 Due: 12/31/10

The Safety And Efficacy Of Maintenance Therapy With CP-690,550

Phase: N/A Priority: Normal
NCT ID: NCT01393899 Org: User:
Start: 03/31/12 End: 07/31/15 Due: 07/31/16

A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT06206837 Org: User:
Start: 02/19/24 End: 03/06/26 Due: 03/06/27

A Study to Assess the Relative Bioavailability of a Modified-Release Formulation of PF-05180999

Phase: N/A Priority: Normal
NCT ID: NCT01530529 Org: User:
Start: 01/31/12 End: 04/30/12 Due: 04/30/13

A Study To Assess The Duration Of Action Of PF-03526299 In Asthmatic Subjects Following Allergen Challenge

Phase: N/A Priority: Normal
NCT ID: NCT01299467 Org: User:
Start: 02/28/11 End: 02/29/12 Due: 02/28/13

A Study to Learn How a Tablet Compared With an IV Infusion of the Study Medicine Called Vepdegestrant is Taken up Into the Blood in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06911788 Org: User:
Start: 04/03/25 End: 06/17/25 Due: 06/17/26

Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease

Phase: N/A Priority: Normal
NCT ID: NCT03801928 Org: User:
Start: 02/23/18 End: 02/07/20 Due: 02/07/21

Safety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Studies

Phase: N/A Priority: Normal
NCT ID: NCT00452842 Org: User:
Start: 10/31/07 End: - Due: -

Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART)

Phase: N/A Priority: Normal
NCT ID: NCT05012865 Org: User:
Start: 09/14/21 End: 01/31/22 Due: 01/31/23

A Study To Investigate Palbociclib (PD-0332991) Pharmacokinetics In Healthy Subjects Of Japanese Descent Relative To Healthy Non-Asian Subjects, And To Determine If Changes In Palbociclib Dose Result In Proportional Changes In Palbociclib Plasma Exposure In Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02059330 Org: User:
Start: 03/31/14 End: 06/30/14 Due: 06/30/15

To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.

Phase: N/A Priority: Normal
NCT ID: NCT00143338 Org: User:
Start: 11/30/04 End: 12/31/06 Due: 12/31/07

Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients

Phase: N/A Priority: Normal
NCT ID: NCT01284062 Org: User:
Start: 03/31/11 End: 04/30/13 Due: 04/30/14

Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03575871 Org: User:
Start: 06/29/18 End: 08/13/19 Due: 08/13/20

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04607421 Org: User:
Start: 12/21/20 End: 12/24/26 Due: 12/24/27

A Study To Evaluate The Safety, Tolerability And Plasma Drug Levels Following A Single Dose Of PF-04995274 In Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01091272 Org: User:
Start: 04/30/10 End: 09/30/10 Due: 09/30/11

AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01300052 Org: User:
Start: 01/26/11 End: 06/06/11 Due: 06/06/12

A Study of PF-04217903 in Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00706355 Org: User:
Start: 08/31/08 End: 06/30/11 Due: 06/30/12